Literature DB >> 19180120

Squamous morules are functionally inert elements of premalignant endometrial neoplasia.

Ming-Chieh Lin1, Lesley Lomo, Jan P A Baak, Charis Eng, Tan A Ince, Christopher P Crum, George L Mutter.   

Abstract

Squamous morules are a common component of premalignant glandular lesions that are followed by glandular, rather than squamous, carcinomas. We tested the hypothesis that the appearance of glands associated with morules predicts cancer risk, and undertook molecular testing to determine the clonal and hormonal response properties of admixed squamous and glandular elements. A total of 66 patients with squamous morules in an index endometrial biopsy had follow-up clinical data (average follow-up: interval 31 months, 2.5 biopsies) showing development of carcinoma in 11% (7/66) of cases. The histological appearance of morule-associated glands in the index biopsy was significantly associated with this clinical outcome, with the majority (71%, 5/7) of cancer occurrences following an overtly premalignant lesion (endometrial intraepithelial neoplasia) with squamous morules. Eight endometrial intraepithelial neoplasias with squamous morules were examined by immunohistochemistry for estrogen and progesterone receptors and mitotic activity (Ki-67 antigen percent stained). Glandular components had abundant estrogen and progesterone receptors, and high levels of mitotic activity in all cases. In sharp contrast, all squamous morules were devoid of sex hormone receptors and had undetectable or extremely low-proliferation rates. When mutated, the same specific PTEN mutation was detected in squamous and glandular elements, indicating that both are of common lineage. The clinical and laboratory data are consistent with a model of morule biology in which squamous morules are a hormonally incompetent subpopulation of endometrial glandular lesions. Isolated morules might result from artifactual displacement from their native glandular context, or selective hormonally induced regression of the glandular but not squamous components over time. Subsequent cancer risk, as promoted by estrogens, is greatest when the glandular component has the appearance of endometrial intraepithelial neoplasia. Even isolated morules should be carefully followed, however, to exclude a coexisting undersampled, or occult, glandular lesion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19180120      PMCID: PMC2633489          DOI: 10.1038/modpathol.2008.146

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  25 in total

1.  Molecular identification of latent precancers in histologically normal endometrium.

Authors:  G L Mutter; T A Ince; J P Baak; G A Kust; X P Zhou; C Eng
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

2.  Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation.

Authors:  M Saegusa; I Okayasu
Journal:  J Pathol       Date:  2001-05       Impact factor: 7.996

3.  Diagnosis of premalignant endometrial disease.

Authors:  G L Mutter
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

4.  Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules).

Authors:  Elena F Brachtel; Carolina Sánchez-Estevez; Gema Moreno-Bueno; Jaime Prat; José Palacios; Esther Oliva
Journal:  Am J Surg Pathol       Date:  2005-10       Impact factor: 6.394

5.  Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers.

Authors:  G L Mutter; M C Lin; J T Fitzgerald; J B Kum; J P Baak; J A Lees; L P Weng; C Eng
Journal:  J Natl Cancer Inst       Date:  2000-06-07       Impact factor: 13.506

6.  Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer.

Authors:  Sa Wang; Jeffery Pudney; Joon Song; Gil Mor; Peter E Schwartz; Wenxin Zheng
Journal:  Gynecol Oncol       Date:  2003-02       Impact factor: 5.482

7.  Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.

Authors:  C A Amezcua; J J Lu; J C Felix; F Z Stanczyk; W Zheng
Journal:  Gynecol Oncol       Date:  2000-11       Impact factor: 5.482

8.  Intrauterine progesterone treatment of early endometrial cancer.

Authors:  Fredrick J Montz; Robert E Bristow; Alessandro Bovicelli; Rafael Tomacruz; Robert J Kurman
Journal:  Am J Obstet Gynecol       Date:  2002-04       Impact factor: 8.661

Review 9.  Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia.

Authors:  George L Mutter; Richard J Zaino; Jan P A Baak; Rex C Bentley; Stanley J Robboy
Journal:  Int J Gynecol Pathol       Date:  2007-04       Impact factor: 2.762

10.  Beta-catenin: a transforming actor on many stages.

Authors:  Keiko Miyoshi; Lothar Hennighausen
Journal:  Breast Cancer Res       Date:  2002-12-20       Impact factor: 6.466

View more
  9 in total

1.  A New Classification of Benign, Premalignant, and Malignant Endometrial Tissues Using Machine Learning Applied to 1413 Candidate Variables.

Authors:  Michael J Downing; David J Papke; Svitlana Tyekucheva; George L Mutter
Journal:  Int J Gynecol Pathol       Date:  2020-07       Impact factor: 2.762

2.  Endometrial intraepithelial neoplasia: clinical correlates and outcomes.

Authors:  Luwam G Semere; Emily Ko; Natasha R Johnson; Allison F Vitonis; Laura J Phang; Daniel W Cramer; George L Mutter
Journal:  Obstet Gynecol       Date:  2011-07       Impact factor: 7.661

Review 3.  Management of endometrial precancers.

Authors:  Cornelia L Trimble; Michael Method; Mario Leitao; Karen Lu; Olga Ioffe; Moss Hampton; Robert Higgins; Richard Zaino; George L Mutter
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

Review 4.  [Precursor lesions of endometrial carcinoma].

Authors:  S F Lax
Journal:  Pathologe       Date:  2019-02       Impact factor: 1.011

5.  Morules in fundic gland polyposis: a case report.

Authors:  Giovanni De Petris; Longwen Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

6.  Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors.

Authors:  Mitzi Aguilar; He Zhang; Musi Zhang; Brandi Cantarell; Subhransu S Sahoo; Hao-Dong Li; Ileana C Cuevas; Jayanthi Lea; David S Miller; Hao Chen; Wenxin Zheng; Jeffrey Gagan; Elena Lucas; Diego H Castrillon
Journal:  J Pathol       Date:  2021-03-09       Impact factor: 7.996

7.  Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications.

Authors:  Peter Rambau; Linda E Kelemen; Helen Steed; May Lynn Quan; Prafull Ghatage; Martin Köbel
Journal:  Int J Mol Sci       Date:  2017-02-27       Impact factor: 5.923

8.  A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma.

Authors:  Cécile Le Page; Martin Köbel; Liliane Meunier; Diane M Provencher; Anne-Marie Mes-Masson; Kurosh Rahimi
Journal:  J Pathol Clin Res       Date:  2019-04-20

9.  Does endometrial morular metaplasia represent odontogenic differentiation?

Authors:  Antonio Travaglino; Antonio Raffone; Daniela Russo; Elia Guadagno; Sara Pignatiello; Paola Moretta; Fulvio Zullo; Marialaura Del Basso De Caro; Luigi Insabato; Massimo Mascolo
Journal:  Virchows Arch       Date:  2021-03-05       Impact factor: 4.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.